ARMISTICE CAPITAL, LLC - TENAX THERAPEUTICS INC ownership

TENAX THERAPEUTICS INC's ticker is TENX and the CUSIP is 88032L100. A total of 38 filers reported holding TENAX THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of TENAX THERAPEUTICS INC
ValueSharesWeighting
Q3 2016$2,472,000
-13.0%
1,068,000
-3.8%
0.79%
-26.7%
Q2 2016$2,842,000
+18.5%
1,110,000
-5.1%
1.08%
+14.9%
Q1 2016$2,399,000
-26.1%
1,170,000
+18.2%
0.94%
-18.7%
Q4 2015$3,247,000
+1120.7%
990,000
+1015.6%
1.16%
+1173.6%
Q3 2015$266,00088,7390.09%
Other shareholders
TENAX THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,163,363$300,0000.02%
Cardinal Capital Management 10,000$6,0000.00%
Verition Fund Management LLC 32,140$18,0000.00%
WFG Advisors, LP 15,000$8,0000.00%
BANK OF AMERICA CORP /DE/ 79$00.00%
WELLS FARGO & COMPANY/MN 26$00.00%
NORTHERN TRUST CORP 51,187$29,0000.00%
GROUP ONE TRADING, L.P. 17,153$10,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 91,755$51,0000.00%
MILLENNIUM MANAGEMENT LLC 161,784$91,0000.00%
View complete list of TENAX THERAPEUTICS INC shareholders